Distribution stopped at AmerisourceBergen Orlando facility
DEA claims that AmerisourceBergen did not maintain effective controls against diversion of controlled substances, specifically hydrocodone, to four Internet pharmacies from Jan. 1, 2006, through Jan. 31, 2007.
DEA has temporarily suspended AmerisourceBergen's Orlando, Fla., distribution center's license to distribute DEA controlled substances and listed chemicals. The temporary suspension affects only the Orlando center and only DEA-controlled items. The action may have ramifications for some 1,400 pharmacy customers in Florida. According to AmerisourceBergen, if the temporary suspension is not quickly resolved, alternative arrangements will be made for customers served by the Orlando distribution center. DEA claims that AmerisourceBergen did not maintain effective controls against diversion of controlled substances, specifically hydrocodone, to four Internet pharmacies from Jan. 1, 2006, through Jan. 31, 2007.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
